News & Updates

Show Multimedia Only

Enzalutamide plus radium-223 boosts OS in mCRPC

13 Mar 2026 by

Adding enzalutamide to radium-223 significantly improves overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) compared with enzalutamide alone, according to the phase III EORTC 1333/PEACE-3 trial presented at ASCO GU 2026.

Enzalutamide plus radium-223 boosts OS in mCRPC

13 Mar 2026

Coffee boosts survival in colorectal cancer

12 Mar 2026 by

Drinking coffee appears to confer survival gains and reduce the risk of recurrence in patients with colorectal cancer (CRC), according to a meta-analysis.

Coffee boosts survival in colorectal cancer

12 Mar 2026

TOC pharmacists reduce discharge days of therapy for CAP treatment

12 Mar 2026

Interventions by transitions of care (TOC) pharmacists have significantly shortened discharge days of therapy (DOT) and total DOT for community-acquired pneumonia (CAP) therapy, reports a study.

TOC pharmacists reduce discharge days of therapy for CAP treatment

12 Mar 2026

1HP safe, feasible for tuberculosis prevention in exposed individuals without HIV

12 Mar 2026 by

Treatment with isoniazid and rifapentine (HP) either for 1 month daily (1HP) or 3 months weekly (3HP) results in high rates of treatment success among people with a positive latent tuberculosis infection test and without HIV infection, a study has shown. The 3HP regimen has slightly lower rates of adverse reactions, but neither exhibits superiority to the other.

1HP safe, feasible for tuberculosis prevention in exposed individuals without HIV

12 Mar 2026

Can community pharmacists identify gaps in statin use for ASCVD prevention?

12 Mar 2026

Community pharmacists can effectively recognize treatment gaps in the use of statin therapy for the prevention of atherosclerotic cardiovascular disease (ASCVD) events, suggests a recent study.

Can community pharmacists identify gaps in statin use for ASCVD prevention?

12 Mar 2026

RW data support enfortumab vedotin-pembrolizumab combo as 1L Tx for bladder cancer

12 Mar 2026 by

Real-world (RW) data presented at ASCO GU 2026 support the use of enfortumab vedotin plus pembrolizumab (EV+P) as frontline treatment for advanced urothelial carcinoma (UC).

RW data support enfortumab vedotin-pembrolizumab combo as 1L Tx for bladder cancer

12 Mar 2026

Healthy eating linked to lower stroke risk

12 Mar 2026

For individuals at high risk of cardiovascular disease (CVD), adherence to healthy dietary patterns confers stroke protection, as reported in a study.

Healthy eating linked to lower stroke risk

12 Mar 2026

Mental disorders implicated in acute coronary syndrome

11 Mar 2026

Mental disorders such as anxiety and depression, among others, appear to contribute to an increased risk of acute coronary syndrome (ACS), according to a systematic review and meta-analysis.

Mental disorders implicated in acute coronary syndrome

11 Mar 2026

Prediabetes reversal yields decades-long cardiovascular benefits

11 Mar 2026 by

Remission of prediabetes has been found to substantially lower the risk of cardiovascular morbidity and mortality in a study, and this cardiovascular protection persists for decades.

Prediabetes reversal yields decades-long cardiovascular benefits

11 Mar 2026

Women more likely to achieve blood pressure targets than men

11 Mar 2026

Sex differences exist among individuals with hypertension, as women tend to initiate antihypertensive therapy at lower intensities and are less likely to be uptitrated than men, reveals a recent study.

Women more likely to achieve blood pressure targets than men

11 Mar 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Enzalutamide plus radium-223 boosts OS in mCRPC

Enzalutamide plus radium-223 boosts OS in mCRPC

Coffee boosts survival in colorectal cancer

Coffee boosts survival in colorectal cancer

TOC pharmacists reduce discharge days of therapy for CAP treatment

TOC pharmacists reduce discharge days of therapy for CAP treatment

1HP safe, feasible for tuberculosis prevention in exposed individuals without HIV

1HP safe, feasible for tuberculosis prevention in exposed individuals without HIV

Can community pharmacists identify gaps in statin use for ASCVD prevention?

Can community pharmacists identify gaps in statin use for ASCVD prevention?

RW data support enfortumab vedotin-pembrolizumab combo as 1L Tx for bladder cancer

RW data support enfortumab vedotin-pembrolizumab combo as 1L Tx for bladder cancer

Healthy eating linked to lower stroke risk

Healthy eating linked to lower stroke risk

Mental disorders implicated in acute coronary syndrome

Mental disorders implicated in acute coronary syndrome

Prediabetes reversal yields decades-long cardiovascular benefits

Prediabetes reversal yields decades-long cardiovascular benefits

Women more likely to achieve blood pressure targets than men

Women more likely to achieve blood pressure targets than men